Inclusion Criteria:

- Potential subjects must have had histologically or cytologically confirmed breast
cancer. This includes, but is not limited to: breast cancer-in situ; ductal carcinoma
in situ; lobular carcinoma in situ; cystosarcoma phyllodes; inflammatory breast
carcinoma; invasive breast carcinoma; and breast cancer not otherwise specified;
cancer must be stage 0 through stage III.

- Treatment completion within the past calendar year.

- Age ≥ 18 years. While breast cancer can occur in the pediatric population, the
pediatric population is best served by trials specifically designed for their age
group.

- Life expectancy of greater than 1 year.

- Karnofsky ≥ 60%; see Appendix A.

- Women of childbearing potential are eligible for this study.

- Pregnant women are eligible for this study pending a doctor's note.

- The ability to understand and complete the study questionnaires.

- Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

- Patients who have not recovered from adverse events due to agents administered more
than 4 weeks earlier.

- Patients with known metastasis.

- Patients who are actively participating in a yoga class.

- Known uncontrolled intercurrent illness including, but not limited to, ongoing or
active infection, symptomatic congestive heart failure, unstable angina pectoris,
cardiac arrhythmia, or psychiatric illness/social situations that would compromise
subject health during yoga.